Skip to main content

Adherence to Treatment for Depression

  • Chapter
  • First Online:
Improving Patient Treatment Adherence

Abstract

Major depressive disorder (MDD) is often a chronic, recurrent, and debilitating health problem with a lifetime prevalence of 16.2% and a 12-month prevalence of 6.6% in the USA [1]. Left untreated, depression can have a significant negative impact on a person’s social, physical, and mental well-being and place an enormous burden on society. Patients with depression experience a higher incidence of premature death related to cardiovascular disease [2, 3] and are 4.5 times more likely to suffer a myocardial infarction than those without depression [3]. Depression in patients with diabetes is associated with increasing rates of vascular complications and increased mortality [4]. In terms of economic burden, the total cost of depression in the USA was estimated at $83.1 billion in 2000 [5]. Major contributors to depression-related cost were lost productivity and direct medical expenses, which accounted for $30–$50 billion each year [6]. Compared with nondepressed patients, health service costs for depressed patients are 50–100% greater, mainly due to higher overall medical utilization [7, 8].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Trivedi MH, Lin EH, Katon WJ. Adherence with antidepressant therapy and successful patient self-management. CNS Spectr. 2007;12(8 Suppl 13):1–27.

    PubMed  Google Scholar 

  2. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55:558, 580–592.

    Article  PubMed  CAS  Google Scholar 

  3. Pratt LA, Ford DE, Crum RM, et al. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation. 1996;94:3123–3129.

    Article  PubMed  CAS  Google Scholar 

  4. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diab Care. 2003;26:2822–2828.

    Article  Google Scholar 

  5. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64:1465–1475.

    Article  PubMed  Google Scholar 

  6. Rice DP, Miller LS. Health economics and cost implications of anxiety and other mental disorders in the United States. Br J Psychiatry Suppl. 1998;172(suppl 34):4–9.

    Google Scholar 

  7. Simon GE, VonKorff M. Recognition, management, and outcomes of depression in primary care. ArchFam Med. 1995;4:99–105.

    CAS  Google Scholar 

  8. Henk HJ, Katzelnick DJ, Kobak KA, et al. Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization. Arch Gen Psychiatry. 1996;53:899–904.

    Article  PubMed  CAS  Google Scholar 

  9. Coyne JC, Fechner-Bates S, Schwenk TL. Prevalence, nature, and comorbidity of depressive disorders in primary care. Gen Hospital Psychiatry. 1994;16:267–276.

    Article  CAS  Google Scholar 

  10. Alexander JL, Richardson G, Grypma L, et al. Collaborative depression care, screening, diagnosis and specificity of depression treatments in the primary care setting. Expert Rev Neurother. 2007;7:S59–80.

    Article  Google Scholar 

  11. Katon W, Sullivan M, Walker E. Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med. 2001;134:917–925.

    PubMed  CAS  Google Scholar 

  12. Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diab Care. 2004;27:2154–2160.

    Article  Google Scholar 

  13. Ciechanowski PS, Katon WJ, Russo JE, et al. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25:246–252.

    Article  PubMed  Google Scholar 

  14. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999;14:569–580.

    Article  PubMed  CAS  Google Scholar 

  15. Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. J Am Med Assoc. 1997;277:333–340.

    Article  CAS  Google Scholar 

  16. Judd LL, Paulus MP, Wells KB, et al. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry. 1996;153:1411–1417.

    PubMed  CAS  Google Scholar 

  17. Coulehan JL, Schulberg HC, Block MR, et al. Treating depressed primary care patients improves their physical, mental, and social functioning. Arch Intern Med. 1997;157:1113–1120.

    Article  PubMed  CAS  Google Scholar 

  18. Rost K, Smith JL, Dickinson M. The effect of improving primary care depression management on employee absenteeism and productivity. A randomized trial. Med Care. 2004;42:1202–1210.

    Article  PubMed  Google Scholar 

  19. Demyttenaere K, Mesters P, Boulanger B, et al. Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine. J Affect Disord. 2001;65:243–252.

    Article  PubMed  CAS  Google Scholar 

  20. Demyttenaere K, Enzlin P, Dewe W, et al. Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry. 2001;62(Suppl 22):30–33.

    PubMed  CAS  Google Scholar 

  21. Thompson C, Peveler RC, Stephenson D, et al. Adherence with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and a tricyclic antidepressant. Am J Psychiatry. 2000;157:338–343.

    Article  PubMed  CAS  Google Scholar 

  22. Warden D, Trivedi MH, Wisniewski SR, et al. Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry. 2007;164:1189–1197.

    Article  PubMed  Google Scholar 

  23. Olfson M, Marcus SC, Tedeschi M, et al. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163:101–108.

    Article  PubMed  Google Scholar 

  24. Kobak KA, Taylor L, Katzelnick DJ, et al. Antidepressant medication management and Health Plan Employer Data Information Set (HEDIS) criteria: reasons for nonadherence. J Clin Psychiatry. 2002;63:727–732.

    Article  PubMed  Google Scholar 

  25. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–2107.

    Article  PubMed  CAS  Google Scholar 

  26. Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diab Care. 2005;28:2668–2672.

    Article  Google Scholar 

  27. Akerblad A, Bengtsson F, von Knorring L, et al. Response, remission and relapse in relation to adherence in primary care treatment of depression: A 2-year outcome study. Int Clin Psychopharmacol Bull. 2006;21:117–124.

    Article  Google Scholar 

  28. Peveler R, George C, Kinmonth AL, et al. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. Br Med J. 1999;319:612–615.

    Article  CAS  Google Scholar 

  29. Melfi CA, Chawla AJ, Croghan TW, et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry. 1998;55:1128–1132.

    Article  PubMed  CAS  Google Scholar 

  30. Thase ME, Nierenberg AA, Keller MB, et al. Efficacy of mirtazapine for prevention of depressive relapse: a placebocontrolled double-blind trial of recently remitted high-risk patients. J Clin Psychiatry. 2001;62:782–788.

    Article  PubMed  CAS  Google Scholar 

  31. Lester H, Howe A. Depression in primary care: three key challenges. Postgrad Med J. 2008;84:545–548.

    Article  PubMed  CAS  Google Scholar 

  32. Cooper LA, Gonzales JJ, Gallo JJ, et al. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care. 2003;41:479–489.

    PubMed  Google Scholar 

  33. Schraufnagel TJ, Wagner AW, Miranda J, et al. Treating minority patients with depression and anxiety: what does the evidence tell us? Gen Hosp Psychiatry. 2006;28:27–36.

    Article  PubMed  Google Scholar 

  34. Melartin TK, Rytsala HJ, Leskela US, et al. Continuity is the main challenge in treating major depressive disorder in psychiatric care. J Clin Psychiatry. 2005;66:220–227.

    Article  PubMed  Google Scholar 

  35. Russell J, Kazantzis N. Medication beliefs and adherence to antidepressants in primary care. New Zeal Med J 2008;121:14–20.

    PubMed  Google Scholar 

  36. Halfin A. Depression: the benefits of early and appropriate treatment. Am J Manage Care. 2007;13 (4 Suppl):S92–S97.

    Google Scholar 

  37. Bogner HR, Morales KH, Post EP, et al. Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diab Care. 2007;30:3005–3010.

    Article  Google Scholar 

  38. Carnethon MR, Biggs ML, Barzilay JI, et al. Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med. 2007;167:802–807.

    Article  PubMed  Google Scholar 

  39. Katon W, Fan MY, Unutzer J, et al. Depression and diabetes: a potentially lethal combination. J Gen Intern Med. 2008;23:1571–1575.

    Article  PubMed  Google Scholar 

  40. Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA. 2002;288:1403–1409.

    Article  PubMed  Google Scholar 

  41. Peplau H. Interpersonal relations in nursing. New York, NY: Putnam; 1952.

    Google Scholar 

  42. Guadagnino C. Practicing patient-centered collaborative care (Physician News website), 2006.

    Google Scholar 

  43. Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care. 1995;33:67–74.

    Article  PubMed  CAS  Google Scholar 

  44. Unutzer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836–2845.

    Article  PubMed  Google Scholar 

  45. Lin EH, Katon W, Von Korff M, et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA. 2003;290:2428–2429.

    Article  PubMed  CAS  Google Scholar 

  46. Katon W, Rutter C, Ludman EJ, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001;58:241–247.

    Article  PubMed  CAS  Google Scholar 

  47. Katon WJ, Seelig M. Population-based care of depression: team care approaches to improving outcomes. J Occup Environ Med. 2008;50:459–467.

    Article  PubMed  Google Scholar 

  48. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613.

    Article  PubMed  CAS  Google Scholar 

  49. Ludman E, Katon W, Bush T, et al. Behavioural factors associated with symptom outcomes in a primary care-based depression prevention intervention trial. Psycholog Med. 2003;33:1061–1070.

    Article  CAS  Google Scholar 

  50. Hepner KA, Rowe M, Rost K, et al. The effect of adherence to practice guidelines on depression outcomes. Ann Intern Med. 2007;147:320–329.

    PubMed  Google Scholar 

  51. Cheung AH, Zuckerbrot RA, Jensen PS, et al. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management. Pediatrics. 2007;120:e1313–e1326.

    Article  PubMed  Google Scholar 

  52. Schulberg HC, Katon W, Simon GE, et al. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry. 1998;55:1121–1127.

    Article  PubMed  CAS  Google Scholar 

  53. Spitzer RL, Kroenke K, Williams JBW, et al. Validation and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study. JAMA. 1999;282:1737–1744.

    Article  PubMed  CAS  Google Scholar 

  54. Dobscha SK, Gerrity MS, Corson K, et al. Measuring adherence to depression treatment guidelines in a VA primary care clinic. Gen Hosp Psychiatry. 2003;25:230–237.

    Article  PubMed  Google Scholar 

  55. Nease DE, Jr., Nutting PA, Dickinson WP, et al. Inducing sustainable improvement in depression care in primary care practices. Joint Commission J Q Patient Saf. 2008;34:247–255.

    Google Scholar 

  56. Leveille SG, Huang A, Tsai SB, et al. Health coaching via an internet portal for primary care patients with chronic conditions: a randomized controlled trial. Med. Care. 2009;47:41–47.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carol D. Saur .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Saur, C.D., Steffens, D.C. (2010). Adherence to Treatment for Depression. In: Bosworth, H. (eds) Improving Patient Treatment Adherence. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5866-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-5866-2_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-5865-5

  • Online ISBN: 978-1-4419-5866-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics